Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

CAPRCAPR
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in CAPRICOR THERAPEUTICS INC

JPMORGAN CHASE & CO holds 362,501 shares of CAPR (CAPRICOR THERAPEUTICS INC), worth $8.7M as of 2026-Q2. The position was increased (+5.5% shares). CAPR represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$8.7M

Current Shares

362,501

Total Value Change

+$8.5M

Total Shares Change

+345,821

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
362,501
+5.5%
$8.7M0.0%$24.08
29
2026-Q1
Decreased
343,613
-6.9%
$9.5M0.0%$25.84
0
2025-Q4
Decreased
369,134
-2.8%
$10.7M0.0%$28.96
0
2025-Q3
Increased
379,598
+94.5%
$2.7M0.0%$7.41
42
2025-Q2
Increased
195,189
+1020.2%
$1.9M0.0%$11.15
42
2025-Q1
Increased
17,425
+4.5%
$165,3630.0%$11.50
16
2024-Q4
New
16,680
-
$230,1840.0%$13.76
35

Other major holders of CAPR: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used